Leave Your Message
Engineered for strict bio-potency and targeted therapeutic action across American feedlots, dairy farms, equine racing facilities, and clinical practices.
Examining the dynamics of North American animal health, regulatory transitions under FDA CVM, and advanced biopharmaceutical adoption.
The US animal health market is governed by rigorous FDA Center for Veterinary Medicine (CVM) regulations and USDA biological standards. Suppliers must deliver uncompromised cGMP compliance, validated cold-chain monitoring, and analytical documentation across every active batch.
Modern US agribusiness and companion veterinary care are pivoting from broad-spectrum chemotherapeutics to targeted immunoglobulins, customized antitoxins, and biologicals that reduce antimicrobial resistance (AMR) while boosting herd health indexes.
American commercial feedlots across Texas, Iowa, and Nebraska increasingly rely on predictive health management. Our high-bioavailability APIs and bio-fermentation formulations integrate seamlessly with automated nutritional and dosing systems.
The United States represents the largest and most technologically sophisticated animal health sector globally, encompassing massive livestock industries, concentrated dairy production, an elite equine racing sector, and an expanding pet care ecosystem. Ensuring rapid therapeutic response times in commercial agriculture requires high-purity injectable biologicals such as Tetanus Antitoxin (TAT) and Oxytocin Injection. In feedlot and swine operations, the ability to control postpartum complications, optimize reproductive scheduling, and prevent fatal neurotoxin infections is directly tied to profitability and animal welfare metrics.
Furthermore, American veterinary compounding pharmacies and B2B feed distributors require dependable, highly stable raw materials (APIs), custom pre-mixes, and bio-fermentation inputs that adhere to United States Pharmacopeia (USP) and European Pharmacopoeia (EP) specifications. By maintaining rigorous quality controls, reliable cross-Pacific supply routes, and certified production lines, Jiangxi Serum Pharma provides US partners with dependable bulk stability, reduced batch variance, and consistent multi-ton output capacity.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our dedicated regulatory and technical support team works directly with US-based importers, toll manufacturers, and commercial farms, offering end-to-end documentation including Certificates of Analysis (COA), stability testing data, and custom logistics management designed to navigate FDA import requirements smoothly.
Our premium products bring back health through pure active substances, high-grade veterinary injectables, and functional bio-extracts.
OUR PREMIUM PRODUCTS WILL BRING BACK THE HEALTH.
Our pharmaceutical products consist of biological products, vaccines, western medicines, raw material, intermediates, and medical consumables, with high quality and affordable prices. Tailored specifically to support both human therapeutic manufacturing and veterinary clinical distribution throughout North America.
View Details & PortfolioDerives From The Nature To Maintain Body Health And Balance With Purity.
Our nutritional ingredients cover several categories including plant extracts, plant oils & proteins, probiotics, and other specialties. We are committed to exploring more health ingredients to support human and animal physiological balance.
Explore Nutritional CatalogSerum Pharma continuously monitors the development of cutting-edge markets. Currently, we have cooperated with our partners on the customization of Pre-Mix, Co-Crystallization, and Bio-Fermentation services.
Tailored homogeneous blending of micronutrients and APIs for livestock feeds.
Read MoreEnhanced solubility, stability, and therapeutic delivery profiles for complex molecules.
Read More
Eco-optimized microbial synthesis of advanced biopharmaceutical active substances.
Read MoreStay informed with our latest analytical breakthroughs, market trends, and therapeutic chemistry perspectives.
Exploring the expanding role of botanical squalene as a high-grade adjuvant and carrier in modern animal and human pharmaceutical matrices.
Learn More →
In-depth review of anti-inflammatory glucocorticoid applications in rapid-response veterinary therapy and critical human emergencies.
Learn More →
Analyzing rapid approval processes and metabolic modulation mechanisms shaping the future of global pharmaceutical development.
Learn More →Discover our full spectrum of specialized biological formulations, active ingredients, and biotechnology development capabilities available for US export.
